Active Ingredient: IBANDRONATE SODIUM
Proprietary Name: BONIVA
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: EQ 3MG BASE/3ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021858
Product Number: 001
Approval Date: Jan 6, 2006
Applicant Holder Full Name: HOFFMANN LA ROCHE INC
Marketing Status:
Discontinued
Patent and Exclusivity Information